Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

India is ideal for dermatology trials due to diverse patients and cost-effectiveness.

Monitoring for adverse effects in clinical treatments is crucial.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The treatment combination is effective and generally safe for lung cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The document's conclusion cannot be provided because the content is not available.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Presurgical models can effectively and affordably screen cancer prevention agents.

CTP-543 is generally safe for treating alopecia areata.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.